Global Humira Market
Global Humira Market

Humira Comprehensive Study by Type (Humira Syringe, Humira Pen), Application (Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn's Disease, Other), Sales Channel (OTC Drugs, Prescription Based Drugs) Players and Region - Global Market Outlook to 2024

Humira Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jul 2019 Edition 207 Pages 223 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Humira Market Overview:
Humira (Adalimumab), is an anti-TNF drug used for the treatment of ulcerative colitis, rheumatoid arthritis, Crohn’s disease psoriatic arthritis, etc. When a TNF alpha binds to TBF alpha receptors in an inflammatory response to autoimmune disease, lowers the chances of inflammatory response. Further, increasing prevalence of diseases like arthritis, psoriasis diseases and high investment in R & D of patent drugs and biosimilars are anticipated to propel the market growth.

Market Drivers
  • Increasing Prevalence of Chronic Diseases such as Crohn's Disease
  • Sedentary Lifestyle of Consumers Leading to Growth in Medical Conditions like Arthritis

Market Trend
  • Well Structured Regulatory Framework by the Government for the Humira Drug
  • Increasing Number of Product Pipeline of Humira Drug

Restraints
  • High Cost Factor of Humiria Drug is hampering the Market Growth

Opportunities
  • Focus of Market Players on the Development of Humira Biosimilars for the Treatment of Rheumatoid arthritis and Psoriasis
  • Increasing Investment in Healthcare Infrastructure

Challenges
  • Side Effects associated with the Humira Drugs among Some Patients


Competitive Landscape:
The global Humira market is consolidated with very few players trying to compete with one another on the basis of price. Most of the leading players are focused on the development of Humira biosimilars for the treatment.
Some of the key players profiled in the report are AbbVie Inc.(United States), Eisai Co., Ltd. (Japan), Cadila Pharmaceuticals (India), Torrent Pharmaceuticals Ltd. (India), Amgen Inc. (United States) and Boehringer Ingelheim International GmbH (Germany). Considering Market by Sales Channel, the sub-segment i.e. OTC Drugs will boost the Humira market.

Market Highlights:
June 2018, AbbVie GK and Eisai Co., Ltd. announced that HUMIRA for Subcutaneous Injection 20 mg Syringe 0.2 mL, a new pediatric formulation of HUMIRA (generic name: adalimumab [recombinant], “HUMIRA”), a fully human anti-TNF- monoclonal antibody formulation, was launched after being listed in the National Health Insurance reimbursement price list on June 15, 2018 .

In September 2017, AbbVie GK company won a patent litigation battle with Amgen. Drugmakers AbbVie Inc. and Amgen Inc. reached a patent-dispute settlement requiring Amgen to wait until 2023 to start selling a lower-priced copy of the world’s top-selling drug, AbbVie’s arthritis treatment Humira, in the United States.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Humira market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Humira market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Pharmaceutical Companies, Industry Associations, Potential Investors, Marketing & Consulting Firms, Government and Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Humira Syringe
  • Humira Pen
By Application
  • Ankylosing Spondylitis
  • Rheumatoid Arthritis
  • Crohn's Disease
  • Other
By Sales Channel
  • OTC Drugs
  • Prescription Based Drugs

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Chronic Diseases such as Crohn's Disease
      • 3.2.2. Sedentary Lifestyle of Consumers Leading to Growth in Medical Conditions like Arthritis
    • 3.3. Market Challenges
      • 3.3.1. Side Effects associated with the Humira Drugs among Some Patients
    • 3.4. Market Trends
      • 3.4.1. Well Structured Regulatory Framework by the Government for the Humira Drug
      • 3.4.2. Increasing Number of Product Pipeline of Humira Drug
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Humira, by Type, Application, Sales Channel and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Humira (Value)
      • 5.2.1. Global Humira by: Type (Value)
        • 5.2.1.1. Humira Syringe
        • 5.2.1.2. Humira Pen
      • 5.2.2. Global Humira by: Application (Value)
        • 5.2.2.1. Ankylosing Spondylitis
        • 5.2.2.2. Rheumatoid Arthritis
        • 5.2.2.3. Crohn's Disease
        • 5.2.2.4. Other
      • 5.2.3. Global Humira by: Sales Channel (Value)
        • 5.2.3.1. OTC Drugs
        • 5.2.3.2. Prescription Based Drugs
      • 5.2.4. Global Humira Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Humira (Volume)
      • 5.3.1. Global Humira by: Type (Volume)
        • 5.3.1.1. Humira Syringe
        • 5.3.1.2. Humira Pen
      • 5.3.2. Global Humira by: Application (Volume)
        • 5.3.2.1. Ankylosing Spondylitis
        • 5.3.2.2. Rheumatoid Arthritis
        • 5.3.2.3. Crohn's Disease
        • 5.3.2.4. Other
      • 5.3.3. Global Humira by: Sales Channel (Volume)
        • 5.3.3.1. OTC Drugs
        • 5.3.3.2. Prescription Based Drugs
      • 5.3.4. Global Humira Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Humira (Price)
      • 5.4.1. Global Humira by: Type (Price)
  • 6. Humira: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AbbVie Inc.(United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Eisai Co., Ltd. (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cadila Pharmaceuticals (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Torrent Pharmaceuticals Ltd. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Amgen Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Humira Sale, by Type, Application, Sales Channel and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Humira (Value)
      • 7.2.1. Global Humira by: Type (Value)
        • 7.2.1.1. Humira Syringe
        • 7.2.1.2. Humira Pen
      • 7.2.2. Global Humira by: Application (Value)
        • 7.2.2.1. Ankylosing Spondylitis
        • 7.2.2.2. Rheumatoid Arthritis
        • 7.2.2.3. Crohn's Disease
        • 7.2.2.4. Other
      • 7.2.3. Global Humira by: Sales Channel (Value)
        • 7.2.3.1. OTC Drugs
        • 7.2.3.2. Prescription Based Drugs
      • 7.2.4. Global Humira Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Humira (Volume)
      • 7.3.1. Global Humira by: Type (Volume)
        • 7.3.1.1. Humira Syringe
        • 7.3.1.2. Humira Pen
      • 7.3.2. Global Humira by: Application (Volume)
        • 7.3.2.1. Ankylosing Spondylitis
        • 7.3.2.2. Rheumatoid Arthritis
        • 7.3.2.3. Crohn's Disease
        • 7.3.2.4. Other
      • 7.3.3. Global Humira by: Sales Channel (Volume)
        • 7.3.3.1. OTC Drugs
        • 7.3.3.2. Prescription Based Drugs
      • 7.3.4. Global Humira Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Humira (Price)
      • 7.4.1. Global Humira by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Humira: by Type(USD Million)
  • Table 2. Humira Humira Syringe , by Region USD Million (2013-2018)
  • Table 3. Humira Humira Pen , by Region USD Million (2013-2018)
  • Table 4. Humira: by Application(USD Million)
  • Table 5. Humira Ankylosing Spondylitis , by Region USD Million (2013-2018)
  • Table 6. Humira Rheumatoid Arthritis , by Region USD Million (2013-2018)
  • Table 7. Humira Crohn's Disease , by Region USD Million (2013-2018)
  • Table 8. Humira Other , by Region USD Million (2013-2018)
  • Table 9. Humira: by Sales Channel(USD Million)
  • Table 10. Humira OTC Drugs , by Region USD Million (2013-2018)
  • Table 11. Humira Prescription Based Drugs , by Region USD Million (2013-2018)
  • Table 12. South America Humira, by Country USD Million (2013-2018)
  • Table 13. South America Humira, by Type USD Million (2013-2018)
  • Table 14. South America Humira, by Application USD Million (2013-2018)
  • Table 15. South America Humira, by Sales Channel USD Million (2013-2018)
  • Table 16. Brazil Humira, by Type USD Million (2013-2018)
  • Table 17. Brazil Humira, by Application USD Million (2013-2018)
  • Table 18. Brazil Humira, by Sales Channel USD Million (2013-2018)
  • Table 19. Argentina Humira, by Type USD Million (2013-2018)
  • Table 20. Argentina Humira, by Application USD Million (2013-2018)
  • Table 21. Argentina Humira, by Sales Channel USD Million (2013-2018)
  • Table 22. Rest of South America Humira, by Type USD Million (2013-2018)
  • Table 23. Rest of South America Humira, by Application USD Million (2013-2018)
  • Table 24. Rest of South America Humira, by Sales Channel USD Million (2013-2018)
  • Table 25. Asia Pacific Humira, by Country USD Million (2013-2018)
  • Table 26. Asia Pacific Humira, by Type USD Million (2013-2018)
  • Table 27. Asia Pacific Humira, by Application USD Million (2013-2018)
  • Table 28. Asia Pacific Humira, by Sales Channel USD Million (2013-2018)
  • Table 29. China Humira, by Type USD Million (2013-2018)
  • Table 30. China Humira, by Application USD Million (2013-2018)
  • Table 31. China Humira, by Sales Channel USD Million (2013-2018)
  • Table 32. Japan Humira, by Type USD Million (2013-2018)
  • Table 33. Japan Humira, by Application USD Million (2013-2018)
  • Table 34. Japan Humira, by Sales Channel USD Million (2013-2018)
  • Table 35. India Humira, by Type USD Million (2013-2018)
  • Table 36. India Humira, by Application USD Million (2013-2018)
  • Table 37. India Humira, by Sales Channel USD Million (2013-2018)
  • Table 38. South Korea Humira, by Type USD Million (2013-2018)
  • Table 39. South Korea Humira, by Application USD Million (2013-2018)
  • Table 40. South Korea Humira, by Sales Channel USD Million (2013-2018)
  • Table 41. Taiwan Humira, by Type USD Million (2013-2018)
  • Table 42. Taiwan Humira, by Application USD Million (2013-2018)
  • Table 43. Taiwan Humira, by Sales Channel USD Million (2013-2018)
  • Table 44. Australia Humira, by Type USD Million (2013-2018)
  • Table 45. Australia Humira, by Application USD Million (2013-2018)
  • Table 46. Australia Humira, by Sales Channel USD Million (2013-2018)
  • Table 47. Rest of Asia-Pacific Humira, by Type USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Humira, by Application USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Humira, by Sales Channel USD Million (2013-2018)
  • Table 50. Europe Humira, by Country USD Million (2013-2018)
  • Table 51. Europe Humira, by Type USD Million (2013-2018)
  • Table 52. Europe Humira, by Application USD Million (2013-2018)
  • Table 53. Europe Humira, by Sales Channel USD Million (2013-2018)
  • Table 54. Germany Humira, by Type USD Million (2013-2018)
  • Table 55. Germany Humira, by Application USD Million (2013-2018)
  • Table 56. Germany Humira, by Sales Channel USD Million (2013-2018)
  • Table 57. France Humira, by Type USD Million (2013-2018)
  • Table 58. France Humira, by Application USD Million (2013-2018)
  • Table 59. France Humira, by Sales Channel USD Million (2013-2018)
  • Table 60. Italy Humira, by Type USD Million (2013-2018)
  • Table 61. Italy Humira, by Application USD Million (2013-2018)
  • Table 62. Italy Humira, by Sales Channel USD Million (2013-2018)
  • Table 63. United Kingdom Humira, by Type USD Million (2013-2018)
  • Table 64. United Kingdom Humira, by Application USD Million (2013-2018)
  • Table 65. United Kingdom Humira, by Sales Channel USD Million (2013-2018)
  • Table 66. Netherlands Humira, by Type USD Million (2013-2018)
  • Table 67. Netherlands Humira, by Application USD Million (2013-2018)
  • Table 68. Netherlands Humira, by Sales Channel USD Million (2013-2018)
  • Table 69. Rest of Europe Humira, by Type USD Million (2013-2018)
  • Table 70. Rest of Europe Humira, by Application USD Million (2013-2018)
  • Table 71. Rest of Europe Humira, by Sales Channel USD Million (2013-2018)
  • Table 72. MEA Humira, by Country USD Million (2013-2018)
  • Table 73. MEA Humira, by Type USD Million (2013-2018)
  • Table 74. MEA Humira, by Application USD Million (2013-2018)
  • Table 75. MEA Humira, by Sales Channel USD Million (2013-2018)
  • Table 76. Middle East Humira, by Type USD Million (2013-2018)
  • Table 77. Middle East Humira, by Application USD Million (2013-2018)
  • Table 78. Middle East Humira, by Sales Channel USD Million (2013-2018)
  • Table 79. Africa Humira, by Type USD Million (2013-2018)
  • Table 80. Africa Humira, by Application USD Million (2013-2018)
  • Table 81. Africa Humira, by Sales Channel USD Million (2013-2018)
  • Table 82. North America Humira, by Country USD Million (2013-2018)
  • Table 83. North America Humira, by Type USD Million (2013-2018)
  • Table 84. North America Humira, by Application USD Million (2013-2018)
  • Table 85. North America Humira, by Sales Channel USD Million (2013-2018)
  • Table 86. United States Humira, by Type USD Million (2013-2018)
  • Table 87. United States Humira, by Application USD Million (2013-2018)
  • Table 88. United States Humira, by Sales Channel USD Million (2013-2018)
  • Table 89. Canada Humira, by Type USD Million (2013-2018)
  • Table 90. Canada Humira, by Application USD Million (2013-2018)
  • Table 91. Canada Humira, by Sales Channel USD Million (2013-2018)
  • Table 92. Mexico Humira, by Type USD Million (2013-2018)
  • Table 93. Mexico Humira, by Application USD Million (2013-2018)
  • Table 94. Mexico Humira, by Sales Channel USD Million (2013-2018)
  • Table 95. Humira Sales: by Type(K Units)
  • Table 96. Humira Sales Humira Syringe , by Region K Units (2013-2018)
  • Table 97. Humira Sales Humira Pen , by Region K Units (2013-2018)
  • Table 98. Humira Sales: by Application(K Units)
  • Table 99. Humira Sales Ankylosing Spondylitis , by Region K Units (2013-2018)
  • Table 100. Humira Sales Rheumatoid Arthritis , by Region K Units (2013-2018)
  • Table 101. Humira Sales Crohn's Disease , by Region K Units (2013-2018)
  • Table 102. Humira Sales Other , by Region K Units (2013-2018)
  • Table 103. Humira Sales: by Sales Channel(K Units)
  • Table 104. Humira Sales OTC Drugs , by Region K Units (2013-2018)
  • Table 105. Humira Sales Prescription Based Drugs , by Region K Units (2013-2018)
  • Table 106. South America Humira Sales, by Country K Units (2013-2018)
  • Table 107. South America Humira Sales, by Type K Units (2013-2018)
  • Table 108. South America Humira Sales, by Application K Units (2013-2018)
  • Table 109. South America Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 110. Brazil Humira Sales, by Type K Units (2013-2018)
  • Table 111. Brazil Humira Sales, by Application K Units (2013-2018)
  • Table 112. Brazil Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 113. Argentina Humira Sales, by Type K Units (2013-2018)
  • Table 114. Argentina Humira Sales, by Application K Units (2013-2018)
  • Table 115. Argentina Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 116. Rest of South America Humira Sales, by Type K Units (2013-2018)
  • Table 117. Rest of South America Humira Sales, by Application K Units (2013-2018)
  • Table 118. Rest of South America Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 119. Asia Pacific Humira Sales, by Country K Units (2013-2018)
  • Table 120. Asia Pacific Humira Sales, by Type K Units (2013-2018)
  • Table 121. Asia Pacific Humira Sales, by Application K Units (2013-2018)
  • Table 122. Asia Pacific Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 123. China Humira Sales, by Type K Units (2013-2018)
  • Table 124. China Humira Sales, by Application K Units (2013-2018)
  • Table 125. China Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 126. Japan Humira Sales, by Type K Units (2013-2018)
  • Table 127. Japan Humira Sales, by Application K Units (2013-2018)
  • Table 128. Japan Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 129. India Humira Sales, by Type K Units (2013-2018)
  • Table 130. India Humira Sales, by Application K Units (2013-2018)
  • Table 131. India Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 132. South Korea Humira Sales, by Type K Units (2013-2018)
  • Table 133. South Korea Humira Sales, by Application K Units (2013-2018)
  • Table 134. South Korea Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 135. Taiwan Humira Sales, by Type K Units (2013-2018)
  • Table 136. Taiwan Humira Sales, by Application K Units (2013-2018)
  • Table 137. Taiwan Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 138. Australia Humira Sales, by Type K Units (2013-2018)
  • Table 139. Australia Humira Sales, by Application K Units (2013-2018)
  • Table 140. Australia Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 141. Rest of Asia-Pacific Humira Sales, by Type K Units (2013-2018)
  • Table 142. Rest of Asia-Pacific Humira Sales, by Application K Units (2013-2018)
  • Table 143. Rest of Asia-Pacific Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 144. Europe Humira Sales, by Country K Units (2013-2018)
  • Table 145. Europe Humira Sales, by Type K Units (2013-2018)
  • Table 146. Europe Humira Sales, by Application K Units (2013-2018)
  • Table 147. Europe Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 148. Germany Humira Sales, by Type K Units (2013-2018)
  • Table 149. Germany Humira Sales, by Application K Units (2013-2018)
  • Table 150. Germany Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 151. France Humira Sales, by Type K Units (2013-2018)
  • Table 152. France Humira Sales, by Application K Units (2013-2018)
  • Table 153. France Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 154. Italy Humira Sales, by Type K Units (2013-2018)
  • Table 155. Italy Humira Sales, by Application K Units (2013-2018)
  • Table 156. Italy Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 157. United Kingdom Humira Sales, by Type K Units (2013-2018)
  • Table 158. United Kingdom Humira Sales, by Application K Units (2013-2018)
  • Table 159. United Kingdom Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 160. Netherlands Humira Sales, by Type K Units (2013-2018)
  • Table 161. Netherlands Humira Sales, by Application K Units (2013-2018)
  • Table 162. Netherlands Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 163. Rest of Europe Humira Sales, by Type K Units (2013-2018)
  • Table 164. Rest of Europe Humira Sales, by Application K Units (2013-2018)
  • Table 165. Rest of Europe Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 166. MEA Humira Sales, by Country K Units (2013-2018)
  • Table 167. MEA Humira Sales, by Type K Units (2013-2018)
  • Table 168. MEA Humira Sales, by Application K Units (2013-2018)
  • Table 169. MEA Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 170. Middle East Humira Sales, by Type K Units (2013-2018)
  • Table 171. Middle East Humira Sales, by Application K Units (2013-2018)
  • Table 172. Middle East Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 173. Africa Humira Sales, by Type K Units (2013-2018)
  • Table 174. Africa Humira Sales, by Application K Units (2013-2018)
  • Table 175. Africa Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 176. North America Humira Sales, by Country K Units (2013-2018)
  • Table 177. North America Humira Sales, by Type K Units (2013-2018)
  • Table 178. North America Humira Sales, by Application K Units (2013-2018)
  • Table 179. North America Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 180. United States Humira Sales, by Type K Units (2013-2018)
  • Table 181. United States Humira Sales, by Application K Units (2013-2018)
  • Table 182. United States Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 183. Canada Humira Sales, by Type K Units (2013-2018)
  • Table 184. Canada Humira Sales, by Application K Units (2013-2018)
  • Table 185. Canada Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 186. Mexico Humira Sales, by Type K Units (2013-2018)
  • Table 187. Mexico Humira Sales, by Application K Units (2013-2018)
  • Table 188. Mexico Humira Sales, by Sales Channel K Units (2013-2018)
  • Table 189. Humira: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Humira: by Type(USD Million)
  • Table 197. Humira Humira Syringe , by Region USD Million (2019-2024)
  • Table 198. Humira Humira Pen , by Region USD Million (2019-2024)
  • Table 199. Humira: by Application(USD Million)
  • Table 200. Humira Ankylosing Spondylitis , by Region USD Million (2019-2024)
  • Table 201. Humira Rheumatoid Arthritis , by Region USD Million (2019-2024)
  • Table 202. Humira Crohn's Disease , by Region USD Million (2019-2024)
  • Table 203. Humira Other , by Region USD Million (2019-2024)
  • Table 204. Humira: by Sales Channel(USD Million)
  • Table 205. Humira OTC Drugs , by Region USD Million (2019-2024)
  • Table 206. Humira Prescription Based Drugs , by Region USD Million (2019-2024)
  • Table 207. South America Humira, by Country USD Million (2019-2024)
  • Table 208. South America Humira, by Type USD Million (2019-2024)
  • Table 209. South America Humira, by Application USD Million (2019-2024)
  • Table 210. South America Humira, by Sales Channel USD Million (2019-2024)
  • Table 211. Brazil Humira, by Type USD Million (2019-2024)
  • Table 212. Brazil Humira, by Application USD Million (2019-2024)
  • Table 213. Brazil Humira, by Sales Channel USD Million (2019-2024)
  • Table 214. Argentina Humira, by Type USD Million (2019-2024)
  • Table 215. Argentina Humira, by Application USD Million (2019-2024)
  • Table 216. Argentina Humira, by Sales Channel USD Million (2019-2024)
  • Table 217. Rest of South America Humira, by Type USD Million (2019-2024)
  • Table 218. Rest of South America Humira, by Application USD Million (2019-2024)
  • Table 219. Rest of South America Humira, by Sales Channel USD Million (2019-2024)
  • Table 220. Asia Pacific Humira, by Country USD Million (2019-2024)
  • Table 221. Asia Pacific Humira, by Type USD Million (2019-2024)
  • Table 222. Asia Pacific Humira, by Application USD Million (2019-2024)
  • Table 223. Asia Pacific Humira, by Sales Channel USD Million (2019-2024)
  • Table 224. China Humira, by Type USD Million (2019-2024)
  • Table 225. China Humira, by Application USD Million (2019-2024)
  • Table 226. China Humira, by Sales Channel USD Million (2019-2024)
  • Table 227. Japan Humira, by Type USD Million (2019-2024)
  • Table 228. Japan Humira, by Application USD Million (2019-2024)
  • Table 229. Japan Humira, by Sales Channel USD Million (2019-2024)
  • Table 230. India Humira, by Type USD Million (2019-2024)
  • Table 231. India Humira, by Application USD Million (2019-2024)
  • Table 232. India Humira, by Sales Channel USD Million (2019-2024)
  • Table 233. South Korea Humira, by Type USD Million (2019-2024)
  • Table 234. South Korea Humira, by Application USD Million (2019-2024)
  • Table 235. South Korea Humira, by Sales Channel USD Million (2019-2024)
  • Table 236. Taiwan Humira, by Type USD Million (2019-2024)
  • Table 237. Taiwan Humira, by Application USD Million (2019-2024)
  • Table 238. Taiwan Humira, by Sales Channel USD Million (2019-2024)
  • Table 239. Australia Humira, by Type USD Million (2019-2024)
  • Table 240. Australia Humira, by Application USD Million (2019-2024)
  • Table 241. Australia Humira, by Sales Channel USD Million (2019-2024)
  • Table 242. Rest of Asia-Pacific Humira, by Type USD Million (2019-2024)
  • Table 243. Rest of Asia-Pacific Humira, by Application USD Million (2019-2024)
  • Table 244. Rest of Asia-Pacific Humira, by Sales Channel USD Million (2019-2024)
  • Table 245. Europe Humira, by Country USD Million (2019-2024)
  • Table 246. Europe Humira, by Type USD Million (2019-2024)
  • Table 247. Europe Humira, by Application USD Million (2019-2024)
  • Table 248. Europe Humira, by Sales Channel USD Million (2019-2024)
  • Table 249. Germany Humira, by Type USD Million (2019-2024)
  • Table 250. Germany Humira, by Application USD Million (2019-2024)
  • Table 251. Germany Humira, by Sales Channel USD Million (2019-2024)
  • Table 252. France Humira, by Type USD Million (2019-2024)
  • Table 253. France Humira, by Application USD Million (2019-2024)
  • Table 254. France Humira, by Sales Channel USD Million (2019-2024)
  • Table 255. Italy Humira, by Type USD Million (2019-2024)
  • Table 256. Italy Humira, by Application USD Million (2019-2024)
  • Table 257. Italy Humira, by Sales Channel USD Million (2019-2024)
  • Table 258. United Kingdom Humira, by Type USD Million (2019-2024)
  • Table 259. United Kingdom Humira, by Application USD Million (2019-2024)
  • Table 260. United Kingdom Humira, by Sales Channel USD Million (2019-2024)
  • Table 261. Netherlands Humira, by Type USD Million (2019-2024)
  • Table 262. Netherlands Humira, by Application USD Million (2019-2024)
  • Table 263. Netherlands Humira, by Sales Channel USD Million (2019-2024)
  • Table 264. Rest of Europe Humira, by Type USD Million (2019-2024)
  • Table 265. Rest of Europe Humira, by Application USD Million (2019-2024)
  • Table 266. Rest of Europe Humira, by Sales Channel USD Million (2019-2024)
  • Table 267. MEA Humira, by Country USD Million (2019-2024)
  • Table 268. MEA Humira, by Type USD Million (2019-2024)
  • Table 269. MEA Humira, by Application USD Million (2019-2024)
  • Table 270. MEA Humira, by Sales Channel USD Million (2019-2024)
  • Table 271. Middle East Humira, by Type USD Million (2019-2024)
  • Table 272. Middle East Humira, by Application USD Million (2019-2024)
  • Table 273. Middle East Humira, by Sales Channel USD Million (2019-2024)
  • Table 274. Africa Humira, by Type USD Million (2019-2024)
  • Table 275. Africa Humira, by Application USD Million (2019-2024)
  • Table 276. Africa Humira, by Sales Channel USD Million (2019-2024)
  • Table 277. North America Humira, by Country USD Million (2019-2024)
  • Table 278. North America Humira, by Type USD Million (2019-2024)
  • Table 279. North America Humira, by Application USD Million (2019-2024)
  • Table 280. North America Humira, by Sales Channel USD Million (2019-2024)
  • Table 281. United States Humira, by Type USD Million (2019-2024)
  • Table 282. United States Humira, by Application USD Million (2019-2024)
  • Table 283. United States Humira, by Sales Channel USD Million (2019-2024)
  • Table 284. Canada Humira, by Type USD Million (2019-2024)
  • Table 285. Canada Humira, by Application USD Million (2019-2024)
  • Table 286. Canada Humira, by Sales Channel USD Million (2019-2024)
  • Table 287. Mexico Humira, by Type USD Million (2019-2024)
  • Table 288. Mexico Humira, by Application USD Million (2019-2024)
  • Table 289. Mexico Humira, by Sales Channel USD Million (2019-2024)
  • Table 290. Humira Sales: by Type(K Units)
  • Table 291. Humira Sales Humira Syringe , by Region K Units (2019-2024)
  • Table 292. Humira Sales Humira Pen , by Region K Units (2019-2024)
  • Table 293. Humira Sales: by Application(K Units)
  • Table 294. Humira Sales Ankylosing Spondylitis , by Region K Units (2019-2024)
  • Table 295. Humira Sales Rheumatoid Arthritis , by Region K Units (2019-2024)
  • Table 296. Humira Sales Crohn's Disease , by Region K Units (2019-2024)
  • Table 297. Humira Sales Other , by Region K Units (2019-2024)
  • Table 298. Humira Sales: by Sales Channel(K Units)
  • Table 299. Humira Sales OTC Drugs , by Region K Units (2019-2024)
  • Table 300. Humira Sales Prescription Based Drugs , by Region K Units (2019-2024)
  • Table 301. South America Humira Sales, by Country K Units (2019-2024)
  • Table 302. South America Humira Sales, by Type K Units (2019-2024)
  • Table 303. South America Humira Sales, by Application K Units (2019-2024)
  • Table 304. South America Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 305. Brazil Humira Sales, by Type K Units (2019-2024)
  • Table 306. Brazil Humira Sales, by Application K Units (2019-2024)
  • Table 307. Brazil Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 308. Argentina Humira Sales, by Type K Units (2019-2024)
  • Table 309. Argentina Humira Sales, by Application K Units (2019-2024)
  • Table 310. Argentina Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 311. Rest of South America Humira Sales, by Type K Units (2019-2024)
  • Table 312. Rest of South America Humira Sales, by Application K Units (2019-2024)
  • Table 313. Rest of South America Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 314. Asia Pacific Humira Sales, by Country K Units (2019-2024)
  • Table 315. Asia Pacific Humira Sales, by Type K Units (2019-2024)
  • Table 316. Asia Pacific Humira Sales, by Application K Units (2019-2024)
  • Table 317. Asia Pacific Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 318. China Humira Sales, by Type K Units (2019-2024)
  • Table 319. China Humira Sales, by Application K Units (2019-2024)
  • Table 320. China Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 321. Japan Humira Sales, by Type K Units (2019-2024)
  • Table 322. Japan Humira Sales, by Application K Units (2019-2024)
  • Table 323. Japan Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 324. India Humira Sales, by Type K Units (2019-2024)
  • Table 325. India Humira Sales, by Application K Units (2019-2024)
  • Table 326. India Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 327. South Korea Humira Sales, by Type K Units (2019-2024)
  • Table 328. South Korea Humira Sales, by Application K Units (2019-2024)
  • Table 329. South Korea Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 330. Taiwan Humira Sales, by Type K Units (2019-2024)
  • Table 331. Taiwan Humira Sales, by Application K Units (2019-2024)
  • Table 332. Taiwan Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 333. Australia Humira Sales, by Type K Units (2019-2024)
  • Table 334. Australia Humira Sales, by Application K Units (2019-2024)
  • Table 335. Australia Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 336. Rest of Asia-Pacific Humira Sales, by Type K Units (2019-2024)
  • Table 337. Rest of Asia-Pacific Humira Sales, by Application K Units (2019-2024)
  • Table 338. Rest of Asia-Pacific Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 339. Europe Humira Sales, by Country K Units (2019-2024)
  • Table 340. Europe Humira Sales, by Type K Units (2019-2024)
  • Table 341. Europe Humira Sales, by Application K Units (2019-2024)
  • Table 342. Europe Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 343. Germany Humira Sales, by Type K Units (2019-2024)
  • Table 344. Germany Humira Sales, by Application K Units (2019-2024)
  • Table 345. Germany Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 346. France Humira Sales, by Type K Units (2019-2024)
  • Table 347. France Humira Sales, by Application K Units (2019-2024)
  • Table 348. France Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 349. Italy Humira Sales, by Type K Units (2019-2024)
  • Table 350. Italy Humira Sales, by Application K Units (2019-2024)
  • Table 351. Italy Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 352. United Kingdom Humira Sales, by Type K Units (2019-2024)
  • Table 353. United Kingdom Humira Sales, by Application K Units (2019-2024)
  • Table 354. United Kingdom Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 355. Netherlands Humira Sales, by Type K Units (2019-2024)
  • Table 356. Netherlands Humira Sales, by Application K Units (2019-2024)
  • Table 357. Netherlands Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 358. Rest of Europe Humira Sales, by Type K Units (2019-2024)
  • Table 359. Rest of Europe Humira Sales, by Application K Units (2019-2024)
  • Table 360. Rest of Europe Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 361. MEA Humira Sales, by Country K Units (2019-2024)
  • Table 362. MEA Humira Sales, by Type K Units (2019-2024)
  • Table 363. MEA Humira Sales, by Application K Units (2019-2024)
  • Table 364. MEA Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 365. Middle East Humira Sales, by Type K Units (2019-2024)
  • Table 366. Middle East Humira Sales, by Application K Units (2019-2024)
  • Table 367. Middle East Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 368. Africa Humira Sales, by Type K Units (2019-2024)
  • Table 369. Africa Humira Sales, by Application K Units (2019-2024)
  • Table 370. Africa Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 371. North America Humira Sales, by Country K Units (2019-2024)
  • Table 372. North America Humira Sales, by Type K Units (2019-2024)
  • Table 373. North America Humira Sales, by Application K Units (2019-2024)
  • Table 374. North America Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 375. United States Humira Sales, by Type K Units (2019-2024)
  • Table 376. United States Humira Sales, by Application K Units (2019-2024)
  • Table 377. United States Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 378. Canada Humira Sales, by Type K Units (2019-2024)
  • Table 379. Canada Humira Sales, by Application K Units (2019-2024)
  • Table 380. Canada Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 381. Mexico Humira Sales, by Type K Units (2019-2024)
  • Table 382. Mexico Humira Sales, by Application K Units (2019-2024)
  • Table 383. Mexico Humira Sales, by Sales Channel K Units (2019-2024)
  • Table 384. Humira: by Type(USD/Units)
  • Table 385. Research Programs/Design for This Report
  • Table 386. Key Data Information from Secondary Sources
  • Table 387. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Humira: by Type USD Million (2013-2018)
  • Figure 5. Global Humira: by Application USD Million (2013-2018)
  • Figure 6. Global Humira: by Sales Channel USD Million (2013-2018)
  • Figure 7. South America Humira Share (%), by Country
  • Figure 8. Asia Pacific Humira Share (%), by Country
  • Figure 9. Europe Humira Share (%), by Country
  • Figure 10. MEA Humira Share (%), by Country
  • Figure 11. North America Humira Share (%), by Country
  • Figure 12. Global Humira: by Type K Units (2013-2018)
  • Figure 13. Global Humira: by Application K Units (2013-2018)
  • Figure 14. Global Humira: by Sales Channel K Units (2013-2018)
  • Figure 15. South America Humira Share (%), by Country
  • Figure 16. Asia Pacific Humira Share (%), by Country
  • Figure 17. Europe Humira Share (%), by Country
  • Figure 18. MEA Humira Share (%), by Country
  • Figure 19. North America Humira Share (%), by Country
  • Figure 20. Global Humira: by Type USD/Units (2013-2018)
  • Figure 21. Global Humira share by Players 2018 (%)
  • Figure 22. Global Humira share by Players (Top 3) 2018(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. AbbVie Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 25. AbbVie Inc.(United States) Revenue: by Geography 2018
  • Figure 26. Eisai Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Eisai Co., Ltd. (Japan) Revenue: by Geography 2018
  • Figure 28. Cadila Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 29. Cadila Pharmaceuticals (India) Revenue: by Geography 2018
  • Figure 30. Torrent Pharmaceuticals Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 31. Torrent Pharmaceuticals Ltd. (India) Revenue: by Geography 2018
  • Figure 32. Amgen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Amgen Inc. (United States) Revenue: by Geography 2018
  • Figure 34. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2018
  • Figure 36. Global Humira: by Type USD Million (2019-2024)
  • Figure 37. Global Humira: by Application USD Million (2019-2024)
  • Figure 38. Global Humira: by Sales Channel USD Million (2019-2024)
  • Figure 39. South America Humira Share (%), by Country
  • Figure 40. Asia Pacific Humira Share (%), by Country
  • Figure 41. Europe Humira Share (%), by Country
  • Figure 42. MEA Humira Share (%), by Country
  • Figure 43. North America Humira Share (%), by Country
  • Figure 44. Global Humira: by Type K Units (2019-2024)
  • Figure 45. Global Humira: by Application K Units (2019-2024)
  • Figure 46. Global Humira: by Sales Channel K Units (2019-2024)
  • Figure 47. South America Humira Share (%), by Country
  • Figure 48. Asia Pacific Humira Share (%), by Country
  • Figure 49. Europe Humira Share (%), by Country
  • Figure 50. MEA Humira Share (%), by Country
  • Figure 51. North America Humira Share (%), by Country
  • Figure 52. Global Humira: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • AbbVie Inc.(United States)
  • Eisai Co., Ltd. (Japan)
  • Cadila Pharmaceuticals (India)
  • Torrent Pharmaceuticals Ltd. (India)
  • Amgen Inc. (United States)
  • Boehringer Ingelheim International GmbH (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation